Production of human UDP-glucuronosyltransferases 1A6 and 1A9 using the Semliki Forest virus expression system

被引:6
|
作者
Forsman, T
Lautala, P
Lundström, K
Monastyrskaia, K
Ouzzine, M
Burchell, B
Taskinen, J
Ulmanen, I
机构
[1] Univ Helsinki, Orion Pharma, Bioctr 1A, Mol Biol & Target Prot Res, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Dept Pharm, Div Pharmaceut Chem, FIN-00014 Helsinki, Finland
[3] Roche Ltd, F Hoffmann La Roche, Res Labs, Basel, Switzerland
[4] Givaudan Roure Forsch AG, Dubendorf, Switzerland
[5] Univ Nancy 1, CNRS, UMR 7561, F-54506 Vandoeuvre Nancy, France
[6] Univ Dundee, Ninewells Hosp & Med Sch, Dept Mol & Cellular Pathol, Dundee DD1 9SY, Scotland
[7] Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland
关键词
Semliki Forest virus system; UDP-glucuronosyltransferases UGT1A6 and UGT1A9; mammalian cell expression; RT-PCR;
D O I
10.1016/S0024-3205(00)00831-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Human UDP-glucuronosyltransferases (UGTs) 1A6 and 1A9 were expressed using Semliki Forest virus (SFV) vectors. Infection of chinese hamster lung fibroblast V79 cells with recombinant SFV-UGT viruses resulted in efficient protein expression as detected by metabolic labeling, Western blot analyses and immunofluorescence microscopy. The expression of UGT1A6 and UGT1A9 in the SFV-infected cells was approximately two fold higher than in a stable V79 cell line. No UGT signal was detected in noninfected cells. In addition, SFV-UGT viruses also efficiently infected other mammalian cells, such as baby hamster kidney (BHK), chinese hamster ovary (CHO) and human lung (WI-26 VA4) cells leading to high production of recombinant enzyme. The measurement of enzyme activities and kinetic parameters using p-nitrophenol and nitrocatechol (entacapone) as substrates for UGT1A6 and UGT1A9, respectively, showed that the overall kinetic properties of the enzymes produced by the two systems were similar. We conclude that the SFV expression system represents an efficient, fast and versatile method for production of metabolic enzymes for in vitro assays. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:2473 / 2484
页数:12
相关论文
共 50 条
  • [1] Genetic variants of UDP-glucuronosyltransferases 1A1, 1A6, and 1A9 in cynomolgus and rhesus macaques
    Uno, Yasuhiro
    Mikami, Takahiro
    Tsukazaki, Yasuko
    Nakanishi, Yasuharu
    Murayama, Norie
    Ikushiro, Shinichi
    Tsusaki, Hideshi
    Yamazaki, Hiroshi
    XENOBIOTICA, 2021, 51 (01) : 115 - 121
  • [2] The Development of UDP-Glucuronosyltransferases 1A1 and 1A6 in the Pediatric Liver
    Miyagi, Shogo J.
    Collier, Abby C.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (05) : 912 - 919
  • [3] UDP-Glucuronosyltransferases 1A6 and 1A9 are the Major Isozymes Responsible for the 7-O-Glucuronidation of Esculetin and 4-Methylesculetin in Human Liver Microsomes
    Zhu, Lijun
    Lu, Linlin
    Zeng, Shan
    Luo, Feifei
    Dai, Peimin
    Wu, Peng
    Wang, Ying
    Liu, Liang
    Hu, Ming
    Liu, Zhongqiu
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (07) : 977 - 983
  • [4] Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10
    Sten, Taina
    Qvisen, Saana
    Uutela, Paivi
    Luukkanen, Leena
    Kostiainen, Risto
    Finel, Moshe
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (09) : 1488 - 1494
  • [5] UDP-glucuronosyltransferases 1A6 and 1A10 catalyze reduced menadione glucuronidation
    Nishiyarna, Takahito
    Ohnuma, Tornokazu
    Inoue, Yuu
    Kishi, Takehiko
    Ogura, Kenichiro
    Hiratsuka, Akira
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 371 (02) : 247 - 250
  • [6] Inhibition of Serotonin Metabolic Enzyme UDP-Glucuronosyltransferases (UGT) 1A6 by Ochratoxins
    Yuan, Yang
    Du, Peng
    Yang, Shumei
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (02): : 412 - 415
  • [7] Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity
    Mutlib, AE
    Goosen, TC
    Bauman, JN
    Williams, JA
    Kulkarni, S
    Kostrubsky, S
    CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (05) : 701 - 709
  • [8] Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver
    Mano, Yuji
    Usui, Takashi
    Kamimura, Hidetaka
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (03) : 289 - 296
  • [9] Stereoselective Metabolism of Propranolol Glucuronidation by Human UDP-Glucuronosyltransferases 2B7 and 1A9
    Yu, Lushan
    Qian, Minrong
    Liu, Yao
    Yao, Tongwei
    Zeng, Su
    CHIRALITY, 2010, 22 (04) : 456 - 461
  • [10] Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver
    Yuji Mano
    Takashi Usui
    Hidetaka Kamimura
    European Journal of Clinical Pharmacology, 2007, 63 : 289 - 296